Stockreport

Esperion Therapeutics Inc (ESPR) Reports Strong Revenue Growth in Q4 and FY 2023 [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Net Product Revenue : U.S. net product revenue for Q4 grew by 39% Y/Y to $20.8 million; FY growth of 40% to $78.3 million. Settlement Impact : Received $100 million i [Read more]